ICAM1 and melanoma: Specifically, we injected 5 × 105in vitro-activated OT1 T cells intratumorally into B16-VEGFC mouse melanoma tumors [with intense lymphatic vascularization (25), Supplementary Figure 1A] that had been pre-treated 8 h earlier with an ICAM-1 blocking antibody.